Established in 2003, BIOAXXESS started as a UK technology and business consultancy for innovative research biochemicals and diagnostics kits.

We were involved in the worldwide launch and product development of PEVIVA’s M30 Apoptosense® ELISA, which back in 2000 was distributed by ALEXIS Biochemicals, Switzerland.

Since 2011 we act as PEVIVA’s (now VLVbio’s) apoptosis biomarker assay expert and distributor in the UK and the Republic of Ireland.

We serve customers from >50 UK hospitals and universities, but also pharma and biotech in R&D and through CROs for drug safety and mechanistic cell death biomarker analysis in clinical trials. Through our long-standing unique assay insight and close collaboration with key opinion leaders, BIOAXXESS becomes your partner of choice for your biomarker project.

Since 2009 BIOAXXESS UK also advises on and distribute CANDOR Bioscience immunoassay reagents in the UK and the Republic of Ireland. We provide access to professional development tools to diagnostic kit manufacturers and academic researchers alike:

Get in touch and see how we can help you to achieve your goals:

Contact Us

In Business for ScienceTM


PEVIVA is the original developer and manufacturer of the well-established M30-CytoDEATHTM Monoclonal Antibody directed against the caspase-cleaved neo-epitope M30 of Cytokeratin-18 (K18Asp396-NE, ccK18, K18F-M30).

Visit PEVIVA Shop

View Webinar on PEVIVA Products

Biomarkers in NASH Drug Development: Using Cytokeratin 18 as a Secondary Endpoint in Clinical Trials

60mins on Biomarkers, Clinical Trials, Life Sciences, Pharmaceutical
Monday, October 22, 2018 | 11am EDT (NA) / 4pm BST (UK) / 5pm CEST (EU-Central)

Read Blog

BIOAXXESS UK Powering CANDOR Biosciences

CANDOR Biosciences is an international leader in the development and manufacturing of the optimal buffer solution for every immuno-assay application to help you to increase the analytical reliability and efficiency.

Visit CANDOR Shop